Hints and tips:
...The news came just two months after the country granted another Indian pharma company the right to make a cheaper version over Bayer’s objections. Bayer sells the branded version for $5,355 per month....
...He worked previously at Bayer-Schering and GlaxoSmithKline, the multinational “big pharma” groups, where his former colleagues are equally frustrated about the mood of the markets and shareholder scepticism...
...But Bayer fell 1.9 per cent to €25.73 after it said it was aiming for further earnings growth this year following 2004’s huge restructuring....
...“We believe the announced move is a necessary step in the right direction, but doesn’t change Bayer’s overall weak position in pharma,” the investment bank said....
International Edition